Palleon Pharmaceuticals, a company pioneering glyco-immunology drug development to treat autoimmune diseases and cancer, today announced a collaboration and license agreement with Shanghai Henlius ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback